Suppr超能文献

缺乏前脑啡肽原基因的小鼠中,尼古丁诱导的抗伤害感受、奖赏效应和身体依赖性均降低。

Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.

作者信息

Berrendero Fernando, Mendizábal Victoria, Robledo Patricia, Galeote Lola, Bilkei-Gorzo Andras, Zimmer Andreas, Maldonado Rafael

机构信息

Laboratori de Neurofarmacologia, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain.

出版信息

J Neurosci. 2005 Feb 2;25(5):1103-12. doi: 10.1523/JNEUROSCI.3008-04.2005.

Abstract

It has been shown previously that the endogenous opioid system may be involved in the behavioral effects of nicotine. In the present study, the participation of endogenous enkephalins on nicotine responses has been investigated by using preproenkephalin knock-out mice. Acute nicotine-induced hypolocomotion remained unaffected in these mice. In contrast, antinociception elicited in the tail-immersion and hot-plate tests by acute nicotine administration was reduced in mutant animals. The rewarding properties of nicotine were then investigated using the place-conditioning paradigm. Nicotine induced a conditioned place preference in wild-type animals, but this effect was absent in knock-out mice. Accordingly, in vivo microdialysis studies revealed that the enhancement in dopamine extracellular levels in the nucleus accumbens induced by nicotine was also reduced in preproenkephalin-deficient mice. Finally, the somatic expression of the nicotine withdrawal syndrome precipitated in nicotine-dependent mice by mecamylamine was significantly attenuated in mutant animals. In summary, the present results indicate that endogenous opioid peptides derived from preproenkephalin are involved in the antinociceptive and rewarding properties of nicotine and participate in the expression of physical nicotine dependence.

摘要

先前的研究表明,内源性阿片系统可能参与尼古丁的行为效应。在本研究中,通过使用前脑啡肽原基因敲除小鼠,对内源性脑啡肽在尼古丁反应中的参与情况进行了研究。急性尼古丁诱导的运动减少在这些小鼠中未受影响。相反,在突变动物中,急性给予尼古丁在尾部浸入和热板试验中引起的抗伤害感受作用减弱。然后使用位置条件化范式研究了尼古丁的奖赏特性。尼古丁在野生型动物中诱导了条件性位置偏好,但在基因敲除小鼠中这种效应不存在。相应地,体内微透析研究表明,在前脑啡肽原缺陷小鼠中,尼古丁诱导的伏隔核中多巴胺细胞外水平的升高也降低了。最后,在突变动物中,美加明诱发的尼古丁依赖小鼠体内尼古丁戒断综合征的躯体表现明显减弱。总之,目前的结果表明,源自前脑啡肽原的内源性阿片肽参与了尼古丁的抗伤害感受和奖赏特性,并参与了身体尼古丁依赖的表现。

相似文献

2
Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
J Neurosci. 2002 Dec 15;22(24):10935-40. doi: 10.1523/JNEUROSCI.22-24-10935.2002.
3
Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.
Neuropharmacology. 2009 Jun;56(8):1147-53. doi: 10.1016/j.neuropharm.2009.03.013. Epub 2009 Apr 17.
4
Attenuation of nicotine-induced rewarding effects in A2A knockout mice.
Neuropharmacology. 2006 Sep;51(3):631-40. doi: 10.1016/j.neuropharm.2006.05.005. Epub 2006 Jun 21.
5
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
Neuropharmacology. 2002 Oct;43(5):857-67. doi: 10.1016/s0028-3908(02)00118-1.
6
Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice.
Int J Neuropsychopharmacol. 2009 Jun;12(5):615-25. doi: 10.1017/S1461145708009450. Epub 2008 Oct 21.
7
Influence of δ-opioid receptors in the behavioral effects of nicotine.
Neuropsychopharmacology. 2012 Sep;37(10):2332-44. doi: 10.1038/npp.2012.88. Epub 2012 Jun 6.
8
Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.
J Neurosci. 2003 Jul 2;23(13):5674-83. doi: 10.1523/JNEUROSCI.23-13-05674.2003.
9
Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice.
Drug Alcohol Depend. 2009 Sep 1;104(1-2):175-84. doi: 10.1016/j.drugalcdep.2009.05.015. Epub 2009 Jun 25.
10
Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.
Brain Res. 2008 Jan 16;1189:70-7. doi: 10.1016/j.brainres.2007.10.086. Epub 2007 Nov 7.

引用本文的文献

1
Effect of perioperative transdermal nicotine patch on postoperative pain: A systematic review and meta-analysis.
Indian J Anaesth. 2025 Jul;69(7):664-674. doi: 10.4103/ija.ija_1216_24. Epub 2025 Jun 12.
2
Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders.
Mol Psychiatry. 2024 Jul;29(7):2021-2030. doi: 10.1038/s41380-024-02446-3. Epub 2024 Feb 15.
3
Pharmacological effects of nicotine salts on dopamine release in the nucleus accumbens.
Front Pharmacol. 2023 Sep 28;14:1279512. doi: 10.3389/fphar.2023.1279512. eCollection 2023.
4
Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet.
Exp Ther Med. 2023 Jan 3;25(2):84. doi: 10.3892/etm.2023.11783. eCollection 2023 Feb.
5
The role of enkephalinergic systems in substance use disorders.
Front Syst Neurosci. 2022 Aug 5;16:932546. doi: 10.3389/fnsys.2022.932546. eCollection 2022.
6
A compendium of validated pain genes.
WIREs Mech Dis. 2022 Nov;14(6):e1570. doi: 10.1002/wsbm.1570. Epub 2022 Jun 27.
7
Neurobiological Mechanisms of Nicotine Reward and Aversion.
Pharmacol Rev. 2022 Jan;74(1):271-310. doi: 10.1124/pharmrev.121.000299.
8
Nicotine and opioid co-dependence: Findings from bench research to clinical trials.
Neurosci Biobehav Rev. 2022 Mar;134:104507. doi: 10.1016/j.neubiorev.2021.12.030. Epub 2021 Dec 27.

本文引用的文献

1
Nicotinic acetylcholine receptor agonists: a potential new class of analgesics.
Curr Top Med Chem. 2004;4(3):369-84. doi: 10.2174/1568026043451447.
2
The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.
Nat Rev Neurosci. 2004 Jan;5(1):55-65. doi: 10.1038/nrn1298.
3
Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction.
Eur J Pharmacol. 2003 Nov 7;480(1-3):117-23. doi: 10.1016/j.ejphar.2003.08.099.
7
Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
J Neurosci. 2002 Dec 15;22(24):10935-40. doi: 10.1523/JNEUROSCI.22-24-10935.2002.
8
Cellular and synaptic mechanisms of nicotine addiction.
J Neurobiol. 2002 Dec;53(4):606-17. doi: 10.1002/neu.10148.
9
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
Neuropharmacology. 2002 Oct;43(5):857-67. doi: 10.1016/s0028-3908(02)00118-1.
10
Clinical uses of naltrexone: a review of the evidence.
Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. doi: 10.1037//1064-1297.10.3.213.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验